Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Dysphagia
ADR ID BADD_A01371
ADR Hierarchy
07      Gastrointestinal disorders
07.01      Gastrointestinal signs and symptoms
07.01.06      Gastrointestinal signs and symptoms NEC
07.01.06.003      Dysphagia
Description A disorder characterized by difficulty in swallowing. [CTCAE] Difficulty in SWALLOWING which may result from neuromuscular disorder or mechanical obstruction. Dysphagia is classified into two distinct types: oropharyngeal dysphagia due to malfunction of the PHARYNX and UPPER ESOPHAGEAL SPHINCTER; and esophageal dysphagia due to malfunction of the ESOPHAGUS. [MeSH]
MedDRA Code 10013950
MeSH ID D003680; D003680; D003680
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Deglutition disorder | Disorder deglutition | Dysphagia | Swallowing difficult | Swallowing disorder | Swallowing impaired | Swallowing spasm | Dysphagia aggravated | Aphagia | Oropharyngeal dysphagia | Esophageal dysphagia | Oesophageal dysphagia | Unable to swallow | Deglutition Disorders | Deglutition Disorder | Disorders, Deglutition | Swallowing Disorders | Swallowing Disorder | Oropharyngeal Dysphagia | Dysphagia, Oropharyngeal | Esophageal Dysphagia | Dysphagia, Esophageal
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02434Cinacalcet0.106604%
BADD_D02436Atorvastatin--
BADD_D02438Enoxaparin--
BADD_D02440Lisdexamfetamine0.002104%
BADD_D02441Rasagiline0.026047%
BADD_D02442Magnesium oxide0.001169%
BADD_D02443Tiotropium--
BADD_D02445Solifenacin0.005404%
BADD_D02451Pimavanserin0.018963%
BADD_D02453Midostaurin0.002664%
BADD_D02454Panobinostat0.000533%
BADD_D02455Isavuconazonium-
BADD_D02457Dexmethylphenidate0.003601%
BADD_D02459Dalteparin0.012704%
BADD_D02464Fingolimod--
BADD_D02467Naloxegol0.001830%
BADD_D02468Cannabidiol--
BADD_D02470Nintedanib--
BADD_D02473Sodium chloride--
BADD_D02477Tenofovir alafenamide0.007233%
BADD_D02480Alectinib0.003996%
BADD_D02483Ribociclib0.004263%
BADD_D02486Niraparib0.002664%
BADD_D02489Neratinib--
BADD_D02490Apalutamide0.003677%
BADD_D02491Valbenazine0.018300%
BADD_D02492Deflazacort--
BADD_D02498Abemaciclib--
BADD_D02500Alpelisib0.001865%
BADD_D02502Letermovir0.002170%
The 21th Page    First    Pre   21 22    Next   Last    Total 22 Pages